FN London

Financial News

News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

News

Banks are among the biggest risers on UK’s green light for Oxford-AstraZeneca vaccine

Lenders bounce back after post-Christmas fall as new inoculation is approved

By

Penny Sukhraj

The lift in banking stocks comes a day after bank stocks fell in the first post-Christmas trading, which analysts attributed to a lack of clarity of how markets would operate come 1 January, as the transition period for Brexit ends on 31 December
The lift in banking stocks comes a day after bank stocks fell in the first post-Christmas trading, which analysts attributed to a lack of clarity of how markets would operate come 1 January, as the transition period for Brexit ends on 31 December Photo: Barry Lewis/Getty Images

Banking stocks were among the top climbers on the FTSE 100, which rose on 30 December on the back of the UK government’s approval of the Oxford-AstraZeneca coronavirus vaccine.

Pricing in the news of the vaccine saw an uptick across the banks including NatWest (+2.75%), Lloyds Banking Group (+2.24%), Standard Chartered (+2.03%), HSBC (+1.64%) and Barclays (+1.47%), along with financial services firms like Legal & General (1.81%).

WSJ Logo
British Billionaire Chris Rokos Wants $150 Million for His Florida Mansion

British Billionaire Chris Rokos Wants $150 Million for His Florida Mansion

KKR Floats $1.97 Billion Non-Binding Offer for London-Listed Assura

Bain Capital Ends Pursuit of Fuji Soft

The New Survival Guide for Private Equity: Go Big or Get Back to Basics

Tencent Shares Rise as App Launches DeepSeek Testing